Fidelity International’s Avadel Pharmaceuticals AVDL Stock Holding History

Fidelity International’s Portfolio AVDL Stock Details AVDL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,822,777	Closed	-$60.8M	–	1113
2025 Q4	$60.8M	Buy	+2,822,777	New	+$54.8M	0.05%	314

Other funds holding AVDL

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Fidelity International's AVDL Position: Q1 2026 in Review

Fidelity International sold out of Avadel Pharmaceuticals (AVDL) in Q1 2026, closing a stake of 2,822,777 shares — an estimated $60.8M sold.

Fidelity International first reported a position in AVDL in Q4 2025 and held it in 1 quarter. The position peaked at $60.8M in Q4 2025. 2 funds tracked by Wall St. Rank hold AVDL as of Q1 2026.

Fidelity International reported no remaining Avadel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Fidelity International sold 2,822,777 Avadel Pharmaceuticals shares in Q1 2026, an estimated $60.8M.
Fidelity International first reported a position in Avadel Pharmaceuticals in Q4 2025 and held it in 1 quarter.
Fidelity International's Avadel Pharmaceuticals position peaked at $60.8M in Q4 2025.
2 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2026.

Based on Fidelity International's 13F filing for Q1 2026, filed 15 May 2026.